Heterocyclic-substituted indoles and pharmaceutical compositions
containing them
    10.
    发明授权
    Heterocyclic-substituted indoles and pharmaceutical compositions containing them 失效
    杂环取代的吲哚和含有它们的药物组合物

    公开(公告)号:US4851406A

    公开(公告)日:1989-07-25

    申请号:US904092

    申请日:1986-09-04

    CPC分类号: C07D401/14

    摘要: The present invention provides indole derivatives of the general formula: ##STR1## wherein R.sub.1 is a hydrogen atom or an alkyl, alkenyl, cycloalkyl, cycloalkenyl, carboxyl, cyano, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl or aryl radical, R.sub.2 is a hydrogen atom or an alkyl, trihalogenomethyl, hydroxyl, cycloalkyl, cyano, carboxyl, alkoxycarbonyl, alkylcarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl radical; R.sub.2 is a heterocyclic five-membered ring containing 1 to 4 heteroatoms or a heterocyclic six-membered ring containing 1 to 5 heteroatoms, the heteroatoms of the five- and six-membered rings being the same or different and being nitrogen, oxygen or sulphur and one or more of the nitrogen atoms optionally carrying an oxygen atom, the said five- and six-membered rings optionally being substituted by one or more alkyl, alkoxy, alkylthio, oxo, hydroxyl, nitro, amino, halogen or cyano groups; or R.sub.2 is ##STR2## the tautomers thereof and the physiologically acceptable salts thereof with inorganic and organic acids.The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them.Furthermore, the present invention provides intermediates of the general formula: ##STR3## in which R.sub.1, R.sub.2, A and X have the same meanings as above, and processes for the preparation of these intermediates.

    摘要翻译: 本发明提供以下通式的吲哚衍生物:其中R 1是氢原子或烷基,烯基,环烷基,环烯基,羧基,氰基,烷基羰基,烷氧基羰基,氨基羰基,烷基氨基羰基,二烷基氨基羰基或芳基, R2是氢原子或烷基,三卤代甲基,羟基,环烷基,氰基,羧基,烷氧基羰基,烷基羰基,氨基羰基,烷基氨基羰基或二烷基氨基羰基; R2是含有1至4个杂原子的杂环五元环或含有1至5个杂原子的杂环六元环,五元和六元环的杂原子相同或不同,为氮,氧或硫, 一个或多个氮原子任选地带有氧原子,所述五元和六元环任选被一个或多个烷基,烷氧基,烷硫基,氧代,羟基,硝基,氨基,卤素或氰基取代; 或者R2是其互变异构体及其与无机和有机酸的生理上可接受的盐。 本发明还提供了制备这些化合物的方法和含有它们的药物组合物。 此外,本发明提供通式如下的中间体:其中R1,R2,A和X具有与上述相同的含义,以及制备这些中间体的方法。